Gemini Bio
About Gemini Bio
Gemini Bio is a company based in West Sacramento (United States) founded in 1985 was acquired by BelHealth Investment Partners in September 2018. Gemini Bio has raised $5.68 million across 2 funding rounds from investors including Broadoak Capital Partners and BelHealth Investment Partners. The company has 79 employees as of December 31, 2022. Gemini Bio has completed 1 acquisition, including Orflo. Gemini Bio operates in a competitive market with competitors including MaxCyte, SQZBiotech, Fluxion Biosciences, Berkeley Lights and LBT Innovations, among others.
- Headquarter West Sacramento, United States
- Employees 79 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.68 M (USD)
in 2 rounds
-
Latest Funding Round
$5.68 M (USD), Unspecified
May 10, 2024
-
Investors
Broadoak Capital Partners
& 1 more
-
Employee Count
79
as on Dec 31, 2022
- Investments & Acquisitions
-
Acquired by
BelHealth Investment Partners
(Sep 14, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Gemini Bio
Unlock access to complete
Funding Insights of Gemini Bio
Gemini Bio has successfully raised a total of $5.68M across 2 strategic funding rounds. The most recent funding activity was a Unspecified round of $5.68 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Gemini Bio
Gemini Bio has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Broadoak Capital Partners and BelHealth Investment Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in healthcare businesses, focusing on services, products, and distribution.
|
Locked | Locked | Locked | |
|
Investment banking services are offered in the United States.
|
Locked | Locked | Locked |
Investor details for Gemini Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gemini Bio
Gemini Bio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Orflo.
Investment portfolio details for Gemini Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Instrumentation for cell and protein analysis is developed and marketed.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for Gemini Bio
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Gemini Bio
Detailed financials for Gemini Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gemini Bio Comparisons
Peer comparison for Gemini Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gemini Bio
Gemini Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MaxCyte, SQZBiotech, Fluxion Biosciences, Berkeley Lights and LBT Innovations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instrument systems for cell processing and modification are provided.
|
|
| Locked | Locked | Locked |
Cell therapies are developed using proprietary Cell Squeeze technology.
|
|
| Locked | Locked | Locked |
Microfluidics-based tools for cellular analysis are provided.
|
|
| Locked | Locked | Locked |
Microfluidics-based systems for single-cell isolation and analysis are developed.
|
|
| Locked | Locked | Locked |
Developer of AI-based automated solutions for the preparation and analysis of microbiology culture specimens
|
Detailed competitors of Gemini Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gemini Bio
Complete news archive for Gemini Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gemini Bio
Gemini Bio was founded in 1985 and raised its 1st funding round 36 years after it was founded.
Gemini Bio is headquartered in West Sacramento, United States. It is registered at West Sacramento, California, United States.
Brian Parker is the current CEO of Gemini Bio.
Gemini Bio is a funded company, having raised a total of $5.68M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Gemini Bio is 79.
Gemini Bio was established in 1985 in West Sacramento, United States. Custom media, animal and human sera, buffers, and other supplement reagents are produced by the company for use in academic research, biotechnology, cell and gene therapy, and biopharma sectors. These materials are distributed to scientific communities worldwide to support research and development activities in life sciences.
Gemini Bio's top competitors include MaxCyte, SQZBiotech and Mytos.
Gemini Bio has made 1 acquisition, including Orflo.
Gemini Bio has 2 investors. Key investors include Broadoak Capital Partners, and BelHealth Investment Partners.